Viveve Medical (VIVE) is Reiterated by Maxim Group to Buy, Lowers Price Target to $ 11

Viveve Medical (VIVE) was Reiterated by Maxim Group to “Buy” while Lowering the Price Target of the company shares to $ 11 from a previous price target of $16 . Maxim Group advised their investors in a research report released on Jun 21, 2016.

Viveve Medical

Leave a Reply

Viveve Medical - Is it time to Sell?

Top Brokerage Firms are advising their investors on Viveve Medical. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.